Sweetch offers patient engagement tools to track activity, weight, meals, and habits via a mobile app. The app also provides coaching interventions for patients with chronic conditions such as cardiovascular diseases, diabetes, rheumatoid arthritis, inflammatory bowel disease, and breast cancer . Sweetch is prescribed by a physician along with treatment for illnesses through the company’s B2B partnerships with healthcare organizations, pharma companies, insurers, and healthcare providers.
Funding and financials
In July 2021, raised USD 20 million in a Series A funding round led by Entreé Capital, allocated towards expanding into the US and Brazil, increasing its user base, and developing more AI and Emotional Intelligence-based tools focusing on additional chronic conditions.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.